Table 4.
Univariate and multivariate analysis (logistic regression) predicting prostate cancer and clinically significant cancer
| Diagnosed with PCa | Sig PCa | |||
|---|---|---|---|---|
| Univariate | Multivariate | Univariate | ||
| P value | P value | OR (95% CI) | P value | |
| Age | 0.028 | 0.847 | 1.01 (0.93–1.10) | 0.812 |
| PSA | <0.001 | 0.004 | 1.22 (1.07–1.39) | 0.070 |
| Prostate volume | 0.114 | - | - | 0.397 |
| Prior negative biopsy | 0.541 | - | - | 0.483 |
| MRI lesions per patient | 0.030 | 0.193 | 1.67 (0.77–3.59) | 0.953 |
| Biopsy cores | 0.165 | - | - | 0.587 |
| PI-RAD score | <0.001 | 0.001 | 3.64 (1.74–7.63) | <0.001 |
| 4 + 5 vs 2 + 3 | <0.001 | <0.001 | 10.94 (3.0–40.1) | <0.001 |
PCa prostate cancer, Sig significant, PSA prostate-specific antigen, MRI magnetic resonance imaging